Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors

Published:2017-06-23 Issue:13 Volume:24 Page:1383-1401
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Pećin Ivan¹²,Hartgers Merel L³,Hovingh G Kees³,Dent Ricardo⁴⁵,Reiner Željko¹²

Affiliation:

1. Department of Internal Medicine, University Hospital Centre Zagreb, Croatia

2. School of Medicine, University of Zagreb, Croatia

3. Department of Vascular Medicine, Academic Medical Centre, the Netherlands

4. Amgen (Europe) GmbH, Zug, Switzerland

5. Esperion Therapeutics Inc., Ann Arbor, USA

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2047487317717346

Reference125 articles.

1. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

2. Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia

3. RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES

4. Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis

5. Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia;Circulation;2024-08-27

2. Major cardiovascular events increase in long-term proprotein convertase subtilisin/kexin type 9 inhibitors therapy: the Tuscany cost-effective study;Journal of Cardiovascular Medicine;2023-09-29

3. Retrospective study on clinical efficacy of Evolocumab in highrisk ASCVD patients;Pharmacy Practice;2023-06-30

4. Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges;International Journal of Molecular Sciences;2023-02-07

5. Arterial Stiffness Assessment in Children with Familial Hypercholesterolemia;Management of Dyslipidemia;2021-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3